Ireland submitted its formal bid on 31 July 2017 for Dublin to become the future location of the European Medicines Agency ("EMA") following Brexit. The new location must be decided by the heads of government of the Member States and 18 other cities have submitted bids to compete for the agency. The cities competing with Dublin are Amsterdam, Athens, Barcelona, Bonn, Bratislava, Brussels, Bucharest, Copenhagen, Helsinki, Lille, Malta, Milan, Porto, Sofia, Stockholm, Vienna, Warsaw and Zagreb.
Introducing Dublin's formal bid, Taoiseach Leo Varadkar said that:
"Dublin is a friendly, open, multicultural, cosmopolitan and modern city with excellent infrastructure, outstanding cultural facilities and first rate education institutions."
Minister for Health, Simon Harris committed to increasing the capacity and resources of the Irish medicines regulator, the Health Products Regulatory Authority, to expand its work with the EMA and scale up its regulatory activities in order to assist in the smooth transition to Dublin.
The Irish Government has presented a choice of three high-quality buildings for the new location. The government has also pledged a financial package of78 million over ten years to contribute towards fit-out, rent and maintenance of the new premises. They have also committed a comprehensive relocation support service worth10 million for EMA staff and their families. The bid also emphasises Ireland's strong life sciences and technology sectors and proven ability to attract and retain professionals, providing a rich talent pool for current and future recruitment by the EMA. In short, the Irish government is committed to making the transition from London as smooth and sustainable as possible for the EMA, its...